Glaucoma 2.0: Bench to Bedside CME Objectives

Upon completion of this program, participants should be able to:

• Enhance patient care by evaluating the current global use of neuroprotective drugs for glaucoma and other optic neuropathies
• Triage patients for new testing or therapy through preferred practices
• Improve management skills by evaluating all the risks associated with novel neuroprotective drugs or treatments
• Analyze results of clinical trials in neuroprotection and apply to clinical practice
• Analyze the rationale for emerging treatments for different optic nerve degenerative conditions